Daiichi Sankyo Recalls Welchol Tablets Due to Temperature Abuse During Shipping
Daiichi Sankyo is recalling 68 bottles of Welchol Tablets (colesevelam HCl) 625 mg because they were not stored at controlled room temperature during shipping.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a storage condition deviation (temperature abuse) without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
Daiichi Sankyo Pharma Development is recalling 68 bottles of Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, NDC 65597-701-18. The recall is limited to Lot NVWG with an expiration date of 11/30/2016. The affected products were distributed nationwide.
The recall was initiated because the products were not stored at Controlled Room Temperature as per USP guidelines during shipping. This temperature abuse may affect the quality of the medication.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for a replacement or further instructions.
The recalled product
- Product
- Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 ---NDC 65597-701-18
- Manufacturer
- Daiichi Sankyo Pharma Development
- Category
- Drug — Prescription Medication
- Affected units
- 68
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot NVWG Exp - 11/30/2016
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Daiichi Sankyo Pharma Development under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Daiichi Sankyo Pharma Development
See all →- ModerateBenicar HCT Tablets Recalled for Temperature Abuse During Shipping
FDA (Drugs) · 2014-08-06
- ModerateDaiichi Sankyo Recalls Tribenzor Tablets Due to Temperature Abuse
FDA (Drugs) · 2014-08-06
- ModerateBenicar HCT Tablets Recalled Due to Temperature Abuse During Shipping
FDA (Drugs) · 2014-08-06
- ModerateDaiichi Sankyo Recalls Benicar Tablets Due to Temperature Abuse During Shipping
FDA (Drugs) · 2014-08-06
- ModerateDaiichi Sankyo Recalls Benicar Tablets Due to Temperature Abuse During Shipping
FDA (Drugs) · 2014-08-06
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18